Clinical Trial Update: A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PGX (polymer) for glycemic control and weight loss in overweight/obese individuals with Type II diabetes; the study status is terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• PolyGlycopleX® (PGX®) (polymer-based non-starch polysaccharide)

Snippet

Sponsor: InovoBiologic Inc. | Conditions: Type II Diabetes Mellitus, Obesity | Phase 3 | Status: TERMINATED